The use of hydroxychloroquine in patients with a history of autoimmune blood disorders requires caution due to potential effects on hematopoiesis and blood cell counts.
hydroxychlor 200 mg Hydroxychloroquine has been associated with hematologic adverse reactions, including aplastic anemia and thrombocytopenia, in some cases. Healthcare providers should monitor complete blood counts regularly in patients receiving hydroxychloroquine therapy and adjust treatment as necessary to prevent hematologic complications.